FAZYX
Price
$13.84
Change
+$0.06 (+0.44%)
Updated
May 8 closing price
Net Assets
2.74B
RLBCX
Price
$34.14
Change
+$0.05 (+0.15%)
Updated
May 8 closing price
Net Assets
234.05B
Ad is loading...

FAZYX vs RLBCX

Header iconFAZYX vs RLBCX Comparison
Open Charts FAZYX vs RLBCXBanner chart's image
Fidelity Advisor Multi-Asset Income M
Price$13.84
Change+$0.06 (+0.44%)
VolumeN/A
Net Assets2.74B
American Funds American Balanced R3
Price$34.14
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets234.05B
FAZYX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAZYX vs. RLBCX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAZYX is a Buy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 234B vs. FAZYX (2.74B). FAZYX pays higher dividends than RLBCX: FAZYX (3.68) vs RLBCX (1.70). FAZYX was incepted earlier than RLBCX: FAZYX (10 years) vs RLBCX (23 years). FAZYX (1.08) is less costly to investors than RLBCX (0.89). FAZYX is a more actively managed with annual turnover of: 230.00 vs. RLBCX (44.00). FAZYX has a lower initial minimum investment than RLBCX: FAZYX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 4.39 vs. FAZYX (4.10). FAZYX return over 5 years is better than : 49.04 vs. RLBCX (34.93).
FAZYXRLBCXFAZYX / RLBCX
Total Expense Ratio1.080.89121%
Annual Report Gross Expense Ratio1.080.89121%
Fund Existence10 years23 years-
Gain YTD-1.3810.323-427%
Front Load4%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.74B234B1%
Annual Yield % from dividends3.681.70217%
Returns for 1 year4.104.3993%
Returns for 3 years19.3020.9592%
Returns for 5 years49.0434.93140%
Returns for 10 yearsN/A48.02-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMGYX29.76N/A
N/A
Lord Abbett Growth Opportunities I
SMVFX10.67N/A
N/A
Virtus Ceredex Mid-Cap Value Equity C
OANBX35.46N/A
N/A
Oakmark Equity and Income Institutional
RYECX167.62N/A
N/A
Rydex Energy C
BHCFX17.64N/A
N/A
Baron Health Care Retail